Quintrio
Home

Stock overview

TAT Technologies Ltd

TATT

TAT Technologies Ltd provides solutions and services to the commercial and military aerospace and ground defense industries, focused mainly on three product areas and services: Thermal Management, Power and Actuation, and Maintenance, Repair and Overhaul (MRO). Its product portfolio includes heat exchangers, cooling systems, and mechanical aircraft accessories and systems such as pumps, valves, and turbine power units. Its operating segments are MRO services for aviation components, which derive key revenue, Original equipment manufacturing (OEM) of heat transfer solutions and aviation accessories, MRO services for heat transfer components and OEM of heat transfer solutions, and Overhaul and coating of jet engine components. Geographically, it derives key revenue from the United States.

Last trade $37.65
Day change +$0.26 (+0.70%)
Day range $36.76 – $38.40
Volume 113,038
Market cap $486M

Open XNAS

Fundamentals

Key company ratios and reported financial statements.

Source: Massive.com

Key ratios

No ratio data was found for TATT.

Financial statements

Income and cash flow amounts are for the period; balance sheets are point-in-time snapshots. Amounts are shown in USD. Latest 8 quarterly or 5 annual periods are displayed when available.

No quarterly income statement data was found for TATT.

Recent news

Company coverage with links to the original publishers.

Publication times in UTC
Zacks Investment Research

TAT Technologies Ltd. (TATT) Beats Q3 Earnings and Revenue Estimates

TAT Technologies reported quarterly earnings of $0.58 per share, significantly beating the consensus estimate of $0.38 and surpassing revenue expectations. However, the stock has underperformed the market by 28.8% year-to-date. The company received a Zacks Rank #3 (Hold) rating with mixed estimate revisions, suggesting near-term performance in line with the market.

Zacks Investment Research

Will TAT Technologies (TATT) Beat Estimates Again in Its Next Earnings Report?

TAT Technologies Ltd. (TATT) has demonstrated a strong earnings-beat streak with an average surprise of 30.92% over the last two quarters. The company has a positive Earnings ESP of +4.00% and a Zacks Rank #2 (Buy), suggesting another potential earnings beat in its upcoming report expected on November 2, 2026. Stocks with positive Earnings ESP and Zacks Rank #3 or better historically beat consensus estimates nearly 70% of the time.

Zacks Investment Research

Kratos (KTOS) Earnings Expected to Grow: Should You Buy?

Kratos (KTOS) is expected to report Q3 2026 earnings of $0.21 per share (up 50% YoY) with revenues of $473.69 million (up 36.3% YoY) on November 5. With an Earnings ESP of +8.78% and Zacks Rank #2, the stock is likely to beat consensus estimates. TAT Technologies (TATT) is also positioned to beat earnings with an Earnings ESP of +4.00% and Zacks Rank #2, expected to report $0.38 EPS (up 2.7% YoY).

Zacks Investment Research

TAT Technologies (TATT) Loses 17.2% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner

TAT Technologies Ltd. (TATT) has declined 17.2% over the past four weeks due to heavy selling pressure, but technical and fundamental indicators suggest a potential trend reversal. The stock's RSI reading of 27.99 indicates oversold conditions, while analysts have raised earnings estimates by 0.4% over the last 30 days. TATT holds a Zacks Rank #2 (Buy) rating, positioning it in the top 20% of stocks based on earnings estimate revisions.

GlobeNewswire Inc.

Viridian Therapeutics, Inc. Shareholders Are Encouraged to Reach Out to Johnson Fistel for More Information About Potentially Recovering Their Losses

Johnson Fistel, PLLP announced investigations into potential securities law violations by Viridian Therapeutics, Braskem S.A., and TAT Technologies Ltd. on behalf of investors who suffered losses. The investigation into Viridian focuses on whether the company complied with federal securities laws following its announcement of Phase 3 clinical trial results for its REVEAL-1 trial.

Dividends

Declared distributions and recorded event dates. Forecasts are not shown.

Updated daily

No declared upcoming dividend found.

Ex-dividendAmount / sharePay dateType
Jun 5, 2017$0.3398Jun 21, 2017recurring
Jul 25, 2016$0.3398Aug 9, 2016recurring
Apr 21, 2014$0.2271May 7, 2014recurring
May 1, 2012$0.283May 17, 2012recurring

Stock splits

Historical share-structure events and their execution dates.

Updated daily

No stock split records found.